Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Radiofrequency ablation shows promise as safe, effective way to destroy lung tumors

08.05.2003


Radiofrequency ablation -- using heat to treat cancers – offers some lung cancer patients an alternative to extensive surgery, additional chemotherapy or radiation therapy, a new study shows.



Researchers at the Oncology Institute in Bari, Italy, treated 40 lung nodules found in 18 patients. Fourteen patients had lung metastases and four patients had non-small cell lung cancer that could not be surgically removed. All of the patients had initially undergone chemotherapy for their disease.

Ninety seven percent of the lesions were destroyed by ultrasound guided or CT guided radiofrequency ablation, says Cosmo Gadaleta, MD, principal investigator in the study. One patient with non-small cell lung cancer had evidence of residual disease one month after radiofrequency ablation; that patient was successfully retreated, he says. The patients have been followed for between 2 and 12 months.


Most complications from the treatment were short lasting and easily manageable, adds Dr. Gadaleta. Complications included air and fluid buildup in the lining of the lung, fever, and slight pain. Patients were released from the hospital about a week after treatment, a shorter stay than if they would have undergone surgery, he adds.

“This study shows promise, but we suggest larger studies to better identify patients who could benefit from this therapy and to better assess the role of radiofrequency ablation in the treatment of lung tumors,” Dr. Gadaleta says.


Dr. Gadaleta worked with Vittorio Mattioli, MD and Annamaria Catino, MD on the study. It will be presented May 8 during the American Roentgen Ray Society Annual Meeting in San Diego.


Keri Sperry | EurekAlert!
Further information:
http://www.arrs.org/

More articles from Health and Medicine:

nachricht 'Exciting' discovery on path to develop new type of vaccine to treat global viruses
18.09.2017 | University of Southampton

nachricht A new approach to high insulin levels
18.09.2017 | Schweizerischer Nationalfonds SNF

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

Im Focus: Artificial Enzymes for Hydrogen Conversion

Scientists from the MPI for Chemical Energy Conversion report in the first issue of the new journal JOULE.

Cell Press has just released the first issue of Joule, a new journal dedicated to sustainable energy research. In this issue James Birrell, Olaf Rüdiger,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

New quantum phenomena in graphene superlattices

19.09.2017 | Physics and Astronomy

A simple additive to improve film quality

19.09.2017 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>